These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 23873027)
1. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Chang C; Lee SO; Yeh S; Chang TM Oncogene; 2014 Jun; 33(25):3225-34. PubMed ID: 23873027 [TBL] [Abstract][Full Text] [Related]
2. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Niu Y; Chang TM; Yeh S; Ma WL; Wang YZ; Chang C Oncogene; 2010 Jun; 29(25):3593-604. PubMed ID: 20440270 [TBL] [Abstract][Full Text] [Related]
3. Promotion of bladder cancer development and progression by androgen receptor signals. Miyamoto H; Yang Z; Chen YT; Ishiguro H; Uemura H; Kubota Y; Nagashima Y; Chang YJ; Hu YC; Tsai MY; Yeh S; Messing EM; Chang C J Natl Cancer Inst; 2007 Apr; 99(7):558-68. PubMed ID: 17406000 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation. Hsieh TF; Chen CC; Ma WL; Chuang WM; Hung XF; Tsai YR; Lin MH; Zhang Q; Zhang C; Chang C; Shyr CR Oncol Rep; 2013 Dec; 30(6):2917-22. PubMed ID: 24126741 [TBL] [Abstract][Full Text] [Related]
5. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. Taplin ME; Balk SP J Cell Biochem; 2004 Feb; 91(3):483-90. PubMed ID: 14755679 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471 [TBL] [Abstract][Full Text] [Related]
15. Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells. Chang C; Yeh S; Lee SO; Chang TM Nucl Recept Signal; 2013; 11():e001. PubMed ID: 24653668 [TBL] [Abstract][Full Text] [Related]
16. In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors. Snoek R; Cheng H; Margiotti K; Wafa LA; Wong CA; Wong EC; Fazli L; Nelson CC; Gleave ME; Rennie PS Clin Cancer Res; 2009 Jan; 15(1):39-47. PubMed ID: 19118031 [TBL] [Abstract][Full Text] [Related]
17. Roles of androgen receptor in male and female reproduction: lessons from global and cell-specific androgen receptor knockout (ARKO) mice. Zhou X J Androl; 2010; 31(3):235-43. PubMed ID: 19959826 [TBL] [Abstract][Full Text] [Related]
18. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth. Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860 [TBL] [Abstract][Full Text] [Related]